The Journal of Neuroscience, October 18, 2006, 26(42):10808-10812; doi:10.1523/JNEUROSCI.1661-06.2006
Previous Article | Next Article 
Brief Communications
Blockade of Adenosine A2A Receptors Prevents Protein Phosphorylation in the Striatum Induced by Cortical Stimulation
César Quiroz,1
Catarina Gomes,2
Arlene C. Pak,1
Joaquim A. Ribeiro,2
Steven R. Goldberg,1
Bruce T. Hope,1 and
Sergi Ferré1
1Behavioral Neuroscience Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224, and 2Institute of Pharmacology and Neurosciences, Faculty of Medicine, Institute of Molecular Medicine, University of Lisbon, 1649-028 Lisbon, Portugal
Correspondence should be addressed to Sergi Ferré, Preclinical Pharmacology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224. Email: sferre{at}intra.nida.nih.gov
Previous studies have shown that cortical stimulation selectively activates extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation and immediate early gene expression in striatal GABAergic enkephalinergic neurons. In the present study, we demonstrate that blockade of adenosine A2A receptors with caffeine or a selective A2A receptor antagonist counteracts the striatal activation of cAMPprotein kinase A cascade (phosphorylation of the Ser845 residue of the glutamate receptor 1 subunit of the AMPA receptor) and mitogen-activated protein kinase (ERK1/2 phosphorylation) induced by the in vivo stimulation of corticostriatal afferents. The results indicate that A2A receptors strongly modulate the efficacy of glutamatergic synapses on striatal enkephalinergic neurons.
Key words: caffeine; adenosine A2A receptor; striatum; phosphorylation; ERK1/2; AMPA receptor
Received April 18, 2006;
revised Sept. 11, 2006;
accepted Sept. 11, 2006.
Correspondence should be addressed to Sergi Ferré, Preclinical Pharmacology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224. Email: sferre{at}intra.nida.nih.gov
This article has been cited by other articles:

|
 |

|
 |
 
J. Bertran-Gonzalez, C. Bosch, M. Maroteaux, M. Matamales, D. Herve, E. Valjent, and J.-A. Girault
Opposing Patterns of Signaling Activation in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons in Response to Cocaine and Haloperidol
J. Neurosci.,
May 28, 2008;
28(22):
5671 - 5685.
[Abstract]
[Full Text]
[PDF]
|
 |
|